Abstract

BackgroundThe SIV/rhesus macaque model for HIV/AIDS is a powerful system for examining the contribution of T cells in the control of AIDS viruses. To better our understanding of CD8+ T-cell control of SIV replication in CD4+ T cells, we asked whether TCRs isolated from rhesus macaque CD8+ T-cell clones that exhibited varying abilities to suppress SIV replication could convey their suppressive properties to CD8+ T cells obtained from an uninfected/unvaccinated animal.Principal FindingsWe transferred SIV-specific TCR genes isolated from rhesus macaque CD8+ T-cell clones with varying abilities to suppress SIV replication in vitro into CD8+ T cells obtained from an uninfected animal by retroviral transduction. After sorting and expansion, transduced CD8+ T-cell lines were obtained that specifically bound their cognate SIV tetramer. These cell lines displayed appropriate effector function and specificity, expressing intracellular IFNγ upon peptide stimulation. Importantly, the SIV suppression properties of the transduced cell lines mirrored those of the original TCR donor clones: cell lines expressing TCRs transferred from highly suppressive clones effectively reduced wild-type SIV replication, while expression of a non-suppressing TCR failed to reduce the spread of virus. However, all TCRs were able to suppress the replication of an SIV mutant that did not downregulate MHC-I, recapitulating the properties of their donor clones.ConclusionsOur results show that antigen-specific SIV suppression can be transferred between allogenic T cells simply by TCR gene transfer. This advance provides a platform for examining the contributions of TCRs versus the intrinsic effector characteristics of T-cell clones in virus suppression. Additionally, this approach can be applied to develop non-human primate models to evaluate adoptive T-cell transfer therapy for AIDS and other diseases.

Highlights

  • Our results show that antigen-specific SIV suppression can be transferred between allogenic T cells by TCR gene transfer

  • This advance provides a platform for examining the contributions of TCRs versus the intrinsic effector characteristics of T-cell clones in virus suppression

  • Due to the central role of T lymphocytes in the cellular immune response, adoptive immunotherapy using autologous T cells is being evaluated in cancer treatment trials and as a means to suppress opportunistic virus outbreaks that occur in hematopoietic stem cell transplant patients [1,2,3,4,5,6,7,8,9,10,11,12,13]

Read more

Summary

Introduction

Due to the central role of T lymphocytes in the cellular immune response, adoptive immunotherapy using autologous T cells is being evaluated in cancer treatment trials and as a means to suppress opportunistic virus outbreaks that occur in hematopoietic stem cell transplant patients [1,2,3,4,5,6,7,8,9,10,11,12,13]. Of the key factors in this approach, the isolation of T cells with the appropriate antigen specificity and robust effector functions is paramount. These requirements can be met by transferring highly effective TCR a/b chain gene pairs from donor antigen-specific T cells into recipient CD8+ T cells, thereby reprogramming them to display the antigen specificity of the donor cell [14,15,16,17,18,19,20,21,22,23,24,25,26]. While immune-based therapies hold great theoretical promise, practical treatments have not realized their potential due to an inability to understand the immune basis of immune control of HIV replication, the role CD8+ T cells play, the importance of the many effector functions, and the intrinsic difficulties with formulating and evaluating vaccines against HIV/AIDS. To better our understanding of CD8+ T-cell control of SIV replication in CD4+ T cells, we asked whether TCRs isolated from rhesus macaque CD8+ T-cell clones that exhibited varying abilities to suppress SIV replication could convey their suppressive properties to CD8+ T cells obtained from an uninfected/unvaccinated animal

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.